Cargando…
Structural basis for potent and broad inhibition of HIV-1 RT by thiophene[3,2-d]pyrimidine non-nucleoside inhibitors
Rapid generation of drug-resistant mutations in HIV-1 reverse transcriptase (RT), a prime target for anti-HIV therapy, poses a major impediment to effective anti-HIV treatment. Our previous efforts have led to the development of two novel non-nucleoside reverse transcriptase inhibitors (NNRTIs) with...
Autores principales: | Yang, Yang, Kang, Dongwei, Nguyen, Laura A, Smithline, Zachary B, Pannecouque, Christophe, Zhan, Peng, Liu, Xinyong, Steitz, Thomas A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080946/ https://www.ncbi.nlm.nih.gov/pubmed/30044217 http://dx.doi.org/10.7554/eLife.36340 |
Ejemplares similares
-
Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-d]pyrimidine derivatives as potent HIV-1 NNRTIs
por: Kang, Dongwei, et al.
Publicado: (2020) -
Identification of Novel Diarylpyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors by Exploring the Primer Grip Region
por: Zhang, Tao, et al.
Publicado: (2022) -
Variation in COVID-19 characteristics, treatment and outcomes in Michigan: an observational study in 32 hospitals
por: Chopra, Vineet, et al.
Publicado: (2021) -
Monocyte distribution width as part of a broad pragmatic sepsis screen in the emergency department
por: Malinovska, Alexandra, et al.
Publicado: (2022) -
Dyslipidaemia in HIV-1-infected patients receiving protease inhibitors after initial treatment with first-line-based non-nucleoside reverse transcriptase inhibitors: a cross-sectional study
por: Pefura Yone, Eric Walter, et al.
Publicado: (2012)